Details for 2017754240

Up to date per 03.04.2026

Actions

Title / Product Name

VERWENDUNG VON ADAMTS13 ZUR BEHANDLUNG, LINDERUNG UND/ODER PRÄVENTION EINER VASO-OKKLUSIVEN KRISE BEI SICHELZELLANÄMIE, AKUTER LUNGENLÄSION UND/ODER AKUTEM ATEMSTRESSSYNDROM

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017754240

EP Publication Number

3493830

E-Number

1862947

Language

PCT Number

US17045573

Publication Date

12.06.2019 A

03.12.2025 B1

Registration Date

03.12.2025

AT Publication Date

15.12.2025

Application Date

04.08.2017

Registration Number

Priorities

04.08.2016

201662371030 P

IPC

A61K 38/48 20060101AFI20250704BHEP

Maximum Duration of Protection

04.08.2037

Owner

Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, OsakaJP

Representative

No representatives present

Inventor

EWENSTEIN, Bruce15 Claflin Path Brookline, MA 02445US

GOLDSTEIN, Brahm2694 Dorado Court Thousand Oaks, California 91362US

MAJER, BernhardColloredogasse 25A 1180 ViennaAT

ROSSATO, PaoloLiechtensteinstrasse 3 1090 ViennaAT

SCHEIFLINGER, FriedrichMichelbeuerngasse 4/17 1090 ViennaAT

TURECEK, MariettaFrauenwald 2 3001 MauerbachAT